Abstract:Background and Aims: Erectile dysfunction (ED) is an inability to achieve and maintain erectile rigidity sufficient for satisfactory sexual performance. It is either organic or psychogenic in origin. This study was aimed at establishing vasculogenic causes among patients being evaluated for ED using Penile Doppler Ultrasound. Methods: Fifty-two consecutive patients with the clinical diagnosis of ED were evaluated with color Doppler ultrasound scan using a 7.5 MHz high-frequency linear transducer between July 2016 and June 2019. The examination was commenced 3 min after an intracavernosal injection with 10-20 μg of PGE 1 and continued for 30 min. The measurements were obtained alternately from both deep penile arteries. The variables analyzed were the peak systolic velocity (PSV), end-diastolic velocity (EDV) and resistive index (RI), calculated as (PSV-EDV)/PSV. Erection Hardness was evaluated subjectively using the EH Score (EHS), a 5-point response score denoting how the patient would rate his erection. ED was subjectively assessed using the International Index of Erectile Function (IIEF-5) questionnaire. In patients with a diagnosis of vasculogenic ED, intracavernosal PGE 1 injection was started with a 5 μg dose and then increased in 5 μg increments until the final dose of 20 μg was reached. Results: PSV of cavernosal arteries (CA) varied between 19.2 and 106.2 cm/s (mean: 43.8 ± 18.2) among the entire patients and between 19.7 and 80.2 cm/s (mean: 42.6 ± 11.3) among patients with arteriogenic ED. Arteriogenic ED was found in 8 patients (15.3%), while venogenic ED was observed in 12 patients, which constituted 23% of the entire study population and mixed arteriogenic-venogenic ED was found in 6 patients (11.5%) of the study population. DICC performed on patients diagnosed with venogenic ED on color Doppler ultrasonography revealed venous leakage and no statistically significant differences between results of DICC and color Doppler ultrasonography were found in EDV, RI, and PI measurements ( P <0.005). Among patients with venogenic ED and mixed arteriogenic-venogenic ED,2 patients had a normal erectile response and the remaining 16 received 2 mg phentolamine. A significant increase in PSV between baseline and 20 mg PGE1 ( P < 0.001) was observed in all cases. Following phentolamine, there was a significant increase in grade of erection ( P = 0.0001) and a significant reduction in the EDV ( P = 0.0001). A reduction of the EDV to below 0.0 cm/s was observed in 12 patients. In patients with arteriogenic erectile dysfunction, mean (±standard deviation) duration of erection for consecutive doses of PGE 1 5 μg, 10 μg, 15 μg, and 20 μg were 42.2±18.4, 55.4±24.1, 66.1 ± 31.1, and 83.3±36.7 minutes, respectively, with significant increase for each dose. In patients with veno-occlusive dysfunction, mean durations of erection significantly increased from 9.1±8.0 minutes at 10 μg to 19.2±9.8 minutes at 20 μg. Conclusion: In the current study, 50% of patients had vasculogenic ED and "false-positive'' diagnosis of venous leakage was unmasked by phentolamine re-dosing. It is therefore imperative that patients with ED benefit from duplex color Doppler ultrasonography which is safe, cheap and non-ionizing diagnostic modality before initiating therapy as ED treatment is cause specific.

Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of vasculogenic erectile dysfunction

[Real-Time Rigiscan Monitoring and Color Doppler Ultrasonography in the Diagnosis of Erectile Dysfunction].

Dynamic Observation of Penile Hemodynamic Change in Patients with Vasculogenic Erectile Dysfunction after Prostaglandin E1 Treatment

[The Value of Dynamic Color Duplex Scanning in the Diagnosis of Vascular Erectile Dysfunction].

Evaluation of penile hemodynamics with Doppler ultrasonography combined with oral Sildenafil

Pharmaco-induced erections for penile color-duplex ultrasound: oral PDE5 inhibitors or intracavernosal injection?

Role of duplex ultrasonography,internal pudendal arteriogram and cavernosography in the diagnosis of vascular erectile dysfunction

Ultrasonography after pharmacological stimulation of erection for the diagnosis and therapeutic follow-up of erectile dysfunction due to cavernovenous leakage

Intracaverous injection of aloprostadil sterile power (prostaglandin E1,caverject) for treatment of erectile dysfunction: a 8-Years experience

Oral tadalafil administration plus low dose vasodilator injection: a novel approach to erection induction for penile color duplex ultrasound.

Diagnostic categorization of erectile dysfunction using duplex color doppler ultrasonography and significance of phentolamine redosing in abolishing false diagnosis of venous leak impotence: A single center experience

Pharmacopenile Doppler Ultrasonograpgy in the Diagnosis of Urethral Trauma Associated with Erectile Dysfunction

Timing of penile color flow duplex ultrasonography using a triple drug mixture

The diagnostic value of audiovisual sexual stimulation (AVSS) on erectile dysfunction

Efficient use of penile Doppler ultrasound for investigating men with erectile dysfunction

Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction

AB029. The clinical significance of RigiScan plus detection

Application of dual-energy CT angiography in diagnosis of arterial erectile dysfunction: new scanning technology, new scanning area

[Dynamic Infusion Cavernosometry and Cavernosography for the Diagnosis and Classification of Venous Erectile Dysfunction].

[Penile Hemodynamics in Different Erection Phases].

Study on the hemodynamic parameters of the erection penis evoked by Sildenaifl combined with audio-visual sexual stimulation